Home » Press Releases tagged ‘Supralimus’

Sahajanand Medical Technologies, India Receives CE mark on Two Sirolimus Eluting Coronary Stents.

July 8, 2011 | Author: | Posted in Clinical Trials & Medical Discoveries

June 26, 2011. Surat, India. Sahajanand Medical Technologies (SMT) announced today that it has received European CE marking for two Sirolimus eluting coronary stent systems; Supralimus® (Sirolimus eluting stents on stainless steel platform) & Supralimus-Core® (Sirolimus eluting stent on chromium cobalt platform). The CE approval for Supralimus® and Supralimus-Core® brings the company the distinction of …

Click here to read full Press Release
Tags: , , ,

Six Month Clinical Outcomes of SMT’s Supralimus-Sirolimus Eluting Stent with a Biodegradable Polymer (part of the prospective Multicenter E-Series Registry) is presented at EuroPCR 2009

July 3, 2009 | Author: | Posted in Medical & Pharmaceuticals

About Sahajanand Medical Technologies:
Established in the year 1998, company became the first Indigenous Stent Manufacturer in world to have two DES systems in its product portfolio. It is India’s largest manufacturing company based on Evidence Based Implantable Medical Devices and Medical Equipments. The products are manufactured conforming to the international quality standards and are offered at the most competitive prices. The Company is ISO 9000 certified & also obtained CE certification for its advanced range of products. This gives assurance of company’s quality consciousness. For more information log on to: www.smtpl.com.

Click here to read full Press Release
Tags: , , , ,